Skip to main content
. 2022 Mar 22;98(12):486–498. doi: 10.1212/WNL.0000000000200030

Figure 1. Summary Estimate of the Effects of PTAS + AMM Compared to AMM Alone on 30-Day Risk of Recurrent Stroke or Death.

Figure 1

AMM = aggressive medical management; PTAS = percutaneous transluminal angioplasty and stenting; SAMMPRIS = Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis; VISSIT = Vitesse Intracranial Stent Study for Ischemic Therapy